Corona Virus: Disgusted with India’s ‘Gamechanger drug’

0

Desk : For the last few days, there is a lot of discussion about the hydroxychloroquine, a malaria drug made in India. Apart from the US, Australia and Germany, more than 30 countries have asked India to supply hydroxychloroquine. India is the world’s largest producer of hydroxy chloroquine. This is an anti-malarial medicine, which has been described by the US President Trump Corona virus many times as a game changer. In view of its huge demand, India banned the export of this medicine last week. Although the Trump administration expressed displeasure over this ban, India also announced a partial lifting of the ban.

Scientists and health experts from all countries are rejecting the role of this drug in the fight against corona virus amid growing demand for Made in India hydroxychloroquine. Many scientists have also warned against the widespread use of hydroxychloroquine in the treatment of corona virus.

Limiting effects Hydrochloroquine is commonly used in the treatment of arthritis, lupus, and malaria. The Indian Council of Medical Research (ICMR) has advised people not to take hydrochloroquine without medical advice as not taking the right dosage of chloroquine can have dangerous side effects. ICAR scientist Raman Gangedkar says that this drug can be used for health workers and household members who come in contact with the corona virus infected by the lab. The ICMR has stated in its advisory that hydrochloroquine lab studies have proved to be helpful in the initial defense against corona virus infection. However, the drug has shown limited success in clinical trials.

A study of French scientists published in the International Journal of Antimicrobial Agents (IJAA) last month reported that 20 patients had a decrease in viral load after treatment with hydrochloroquine. In addition, the use of this drug compared to the rest of the patients Viruses were not present in the body of the people for much longer. US President Donald Trump cited this study as a frequent game changer for hydroxychloroquine, but now the publishers of the study have said that it does not meet all the standards.

A study of French scientists published in the International Journal of Antimicrobial Agents (IJAA) last month reported that 20 patients had a decrease in viral load after treatment with hydrochloroquine. In addition, the use of this drug compared to the rest of the patients Viruses were not present in the body of the people for much longer. US President Donald Trump cited this study as a frequent game changer for hydroxychloroquine, but now the publishers of the study have said that it does not meet all the standards.

The researchers started the experiment with 26 patients but had to leave 6 patients in the middle of the trial. According to the study, three patients involved in the trial had to be admitted to the ICU, the fourth patient died, while one patient was complained of vomiting and stopped giving hydroxychloroquine.

Hospitals in Sweden have also stopped using malaria drugs in corona virus patients. This was causing problems like terrible headache and vision loss in patients. A few days after giving this medicine, many patients started seeing side effects like migraine, vomiting, reduced eyesight. In one out of 100, due to chloroquine, heart beat was also seen to fluctuate. Heartbeat may increase or decrease due to rapid heart attack.

According to the medical website Drug Data Fears Pharma, in Europe hydroxychloroquine is being restricted to clinical trials only. Despite initial success in trials in China and France, the European Medicine Agency (EMA) has stated that hydroxychloroquine is not yet proven effective in treating corona virus.

At the same time, Britain has stopped doctors from using this medicine until the clinical trial is over. Well-known UK doctor Professor Anthony Garden told the Daily Mail that there is no evidence yet that chloroquine or hydroxychloroquine is effective in treating the corona virus.

The US Centers for Disease Control and Prevention (CDC) published a guideline regarding the use of hydroxychloroquine in the treatment of corona virus, but it has been removed this week. The CDC has written in an update that the clinical trial of this drug is still going on. Analysts say that the CDC’s guideline regarding hydroxychloroquine was encouraging doctors to use it in the treatment of corona virus. Whereas, in a single clinical trial, it has not been confirmed to be effective and safe.

LEAVE A REPLY

Please enter your comment!
Please enter your name here